News und Analysen
DGAP-Adhoc: DEMIRE Deutsche Mittelstand Real Estate AG: Prognoseerhöhung - FFO I wird Vorjahr übertreffen
DGAP-Adhoc: DEMIRE Deutsche Mittelstand Real Estate AG: Guidance increase - FFO I will exceed previous year's figure
DGAP-News: Erfolgreiches Joint Venture 'Highlands II' erweitert Akquisitionsvolumen um 100 Mio. €
DGAP-News: Successful joint venture 'Highlands II' expands acquisition volume by € 100 million
DGAP-News: CPI PROPERTY GROUP - Recharging our Financial Profile for Growth
DGAP-Adhoc: CPI PROPERTY GROUP - Capital increase
Form 8.3 - Tibra Trading PTY Limited: GCP STUDENT LIVING PLC
DGAP-News: Corestate forciert Integration mit Neueinstellungen in Schlüsselpositionen
DGAP-News: Corestate accelerates integration with new hires in key positions
Aroundtown SA: Release of a capital market information
3 Stocks About to Book Gains on Building Products Demand
Investors often follow the latest trends in the U.S. economy and attempt to align their portfolios with the best industries, some of which could have a breakout in the coming months. The
Going Long Nvidia Still Makes Sense: Here’s Why
Going long NVIDIA (NASDAQ: NVDA) stock still makes sense because the multi-trillion dollar AI opportunity has yet to play out, and Nvidia is the dominating source. Its chipsets, GPUs, and
Semis, Nvidia Set for Big Moves as GTC Conference Kicks Off
Nvidia (NASDAQ: NVDA) is not just on a hot streak; it's setting records. With shares skyrocketing 241% over the past year and a staggering 77% year-to-date, the company has become an indispensable
Stock ideas from the 2024 Microcap Conference
When it comes to investing in micro-cap stocks, it can sometimes be a real challenge to distinguish the potential winners from those that might not offer much near-term upside. However, a great
Tocvan: Auf der Zielgeraden in Richtung Produktion in Sonora
Tocvan Ventures (TOC: CNX, ISIN: CA88900N1050) zählt zu den ganz wenigen Junior-Ressourcenunternehmen, denen es bis dato gelungen ist, einen Doré-Barren zu produzieren. Der Barren wurde
Tocvan: Heading towards Production in Sonora
Tocvan Ventures (TOC: CNX) is one of the very few junior resource companies to have ever produced a doré bar. The bar was produced from the gold and silver heap leached from a bulk
Neue Mehrfamilienhäuser im Kanton St. Gallen zu etwa 95 Prozent vermietet
Antizipiertes verbessertes Gruppenergebnis durch gesteigerten Ertrag
Freienbach (25.01.2024)
Swiss Estates AG hat vor etwa einem Jahr drei Mehrfamilienhäuser im Kanton St. Gallen
Analysts See Strong Upside Trade for Undervalued REITs
Imagine an investment that’s required by law to pass along profits to you.
Well, you don’t have to conjure up some investment that doesn’t exist. Real estate investment trusts, often called
Rockstone Research: Jay Currie sieht Tocvan als Übernahmekandidat oder Cashflow-Maschine
Vollbild / Der Abbau und die Verarbeitung der Großprobe bei Tocvans Pilar Gold-Silber-Projekt im mexikanischen Sonora hat zukunftsweisende Ergebnisse geliefert.
In einem neuen Artikel
3 Construction Stocks That Will Bring Growth This Fall
As summer winds down, business activity is picking up in the construction sector, which was beaten down for much of the year. The possibility for attractive growth in the upcoming quarter commands
7 Best Industrial REITs to Buy Now
If you're looking to capitalize on the industrial real estate sector, industrial real estate investment trusts (REITs), also known as warehouse REITs, are publicly traded companies that own and
3 Volatile Mid-Caps to Trade This Earnings Season
With approximately one-third of the S&P 500 reporting, all eyes will be on large-cap earnings this week. Rest assured, though; there will also be plenty of action in mid-cap land.
Historically
Wochenausblick: Fehlende Impulse für den Markt
Der DAX® konnte seinen anfänglichen Verlust im Verlauf des Handelstages wieder aufholen und endet die Woche mit fast unverändert. Angesicht der Flaute bei den wirtschaftlichen Daten und
shareribs.com - Ölpreise bleiben auf hohem Niveau - Spannungen treiben Preiserwartungen
BioNTech und DualityBio starten zulassungsrelevante Phase-3-Studie mit Antikörper-Wirkstoff-Konjugat-Kandidat BNT323/DB-1303 bei metastasiertem Brustkrebs
- Der Start der zulassungsrelevanten Phase-3-Studie mit BNT323/DB-1303 basiert auf positiven Daten zur Sicherheit und Wirksamkeit aus einer Phase-1/2-Studie bei Brustkrebspatientinnen und -patienten